SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050844
Filing Date
2020-11-05
Accepted
2020-11-05 07:00:31
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-10q_20200930.htm 10-Q 1732383
2 EX-31.1 cycn-ex311_7.htm EX-31.1 9232
3 EX-31.2 cycn-ex312_6.htm EX-31.2 9275
4 EX-32.1 cycn-ex321_8.htm EX-32.1 4960
5 EX-32.2 cycn-ex322_9.htm EX-32.2 4978
  Complete submission text file 0001564590-20-050844.txt   5409687

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycn-20200930.xml EX-101.INS 907884
7 XBRL TAXONOMY EXTENSION SCHEMA cycn-20200930.xsd EX-101.SCH 47798
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycn-20200930_cal.xml EX-101.CAL 44778
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycn-20200930_def.xml EX-101.DEF 143565
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20200930_lab.xml EX-101.LAB 370674
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20200930_pre.xml EX-101.PRE 268712
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 201288595
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences